OR Royalties Inc. (NYSE:OR – Get Free Report) saw some unusual options trading on Tuesday. Stock investors bought 7,046 call options on the company. This represents an increase of 908% compared to the typical daily volume of 699 call options.
Analysts Set New Price Targets
Several research firms have commented on OR. Raymond James Financial upgraded OR Royalties from a “market perform” rating to an “outperform” rating and set a $41.00 target price on the stock in a research note on Thursday, November 6th. Wall Street Zen lowered shares of OR Royalties from a “strong-buy” rating to a “buy” rating in a research note on Sunday. Weiss Ratings restated a “buy (b)” rating on shares of OR Royalties in a report on Monday, December 29th. Zacks Research lowered OR Royalties from a “strong-buy” rating to a “hold” rating in a report on Friday, December 19th. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $38.00 price objective on shares of OR Royalties in a report on Sunday, December 7th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, OR Royalties presently has an average rating of “Moderate Buy” and a consensus price target of $35.75.
Read Our Latest Stock Report on OR Royalties
Institutional Investors Weigh In On OR Royalties
OR Royalties Price Performance
OR traded up $0.69 during trading on Tuesday, hitting $40.81. The stock had a trading volume of 679,552 shares, compared to its average volume of 1,380,995. The company has a 50 day moving average price of $34.72 and a 200-day moving average price of $33.22. OR Royalties has a one year low of $17.55 and a one year high of $42.25. The firm has a market cap of $7.64 billion, a price-to-earnings ratio of 51.65 and a beta of 0.78.
OR Royalties (NYSE:OR – Get Free Report) last released its quarterly earnings results on Wednesday, November 5th. The basic materials company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.03. OR Royalties had a net margin of 60.72% and a return on equity of 10.67%. The business had revenue of $71.63 million for the quarter, compared to analyst estimates of $53.85 million. As a group, sell-side analysts predict that OR Royalties will post 0.62 EPS for the current fiscal year.
OR Royalties Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Wednesday, December 31st will be issued a $0.055 dividend. The ex-dividend date of this dividend is Wednesday, December 31st. This represents a $0.22 annualized dividend and a yield of 0.5%. OR Royalties’s payout ratio is currently 27.85%.
OR Royalties Company Profile
OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.
The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.
Recommended Stories
- Five stocks we like better than OR Royalties
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Receive News & Ratings for OR Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OR Royalties and related companies with MarketBeat.com's FREE daily email newsletter.
